Are another 5 years of adjuvant aromatase inhibitor therapy needed?
Qin-Guo Mo*, De-Quan Li*, Jian-Hong Zhong, Chang-Yuan Wei Department of Breast Surgery, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, People’s Republic of China *These authors contributed equally to this workIn the recent issue of Breast Cancer: Targets and The...
Main Authors: | Mo QG, Li DQ, Zhong JH, Wei CY |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2016-11-01
|
Series: | Breast Cancer : Targets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/letter-adjuvant-systemic-therapy-in-older-women-with-breast-peer-reviewed-article-BCTT |
Similar Items
-
Adjuvant systemic therapy in older women with breast cancer
by: Leone J, et al.
Published: (2016-07-01) -
Potentially Modifiable Factors Associated with Adherence to Adjuvant Endocrine Therapy among Breast Cancer Survivors: A Systematic Review
by: Kirsti I. Toivonen, et al.
Published: (2021-12-01) -
Use of Adjuvant Endocrine Therapy Among Post-Menopausal Breast Cancer Patients in Malaysia
by: Saiful Bahri A, et al.
Published: (2021-02-01) -
Understanding adjuvant endocrine therapy persistence in breast Cancer survivors
by: Leah K. Lambert, et al.
Published: (2018-07-01) -
Does patient health literacy impact adherence to adjuvant endocrine therapy in breast cancer patients?
by: Keim-Malpass J, et al.
Published: (2018-12-01)